Microbiota-focused dietary therapy may improve outcomes for metabolic dysfunction-associated steatotic liver disease (MASLD), as presented at Digestive Disease Week®. Patients with MASLD had poor dietary habits with low fiber and omega-3 intake but high sugars and ultraprocessed food consumption, correlating with specific bacterial species and pathways. Lifestyle modifications, including weight loss and dietary changes, are essential for MASLD management. Mediterranean diet components, like limited carbs and saturated fats, along with high fiber and unsaturated fats, are recommended. A study comparing MASLD and control groups revealed differences in food intake, inflammatory markers, and gut microbiota, highlighting the importance of diet quality in managing MASLD.
Source link
Microbiota-Focused Dietary Therapy Could Improve MASLD
